- Investing Ideas
- /
- Global Large Cap High Growth Potential
Global Large Cap High Growth Potential
Results
627
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
627 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
6181 | HK$493.00 | 14.8% | n/a | HK$83.0b | HK$393.45 | PE95.8x | E38.5% | n/a | Consumer Durables | ||
600760 | CN¥46.31 | -3.4% | 23.7% | CN¥127.6b | CN¥53.90 | PE51.9x | E29.4% | 0.6% | Capital Goods | ||
9992 | HK$110.80 | 9.6% | 477.1% | HK$147.0b | HK$99.76 | PE89.7x | E36.7% | 0.3% | Retail | ||
RHM | €817.00 | 12.9% | 110.5% | €35.5b | €810.71 | PE51.8x | E30.5% | 0.7% | Capital Goods | ||
ONON | US$52.03 | -7.8% | 63.9% | US$16.7b | US$62.83 | PE118.9x | E29.7% | n/a | Consumer Durables | ||
ARES | US$186.18 | -2.2% | 37.9% | US$58.3b | US$198.29 | PE85.2x | E41.4% | 2.4% | Diversified Financials | ||
ALNY | US$256.45 | -7.1% | 74.5% | US$33.2b | US$299.57 | PS14.8x | E58.7% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$138.85 | 6.9% | 91.2% | US$3.4t | US$172.21 | PE53.9x | E21.6% | 0.03% | Semiconductors | ||
300308 | CN¥107.43 | -0.3% | 18.4% | CN¥118.7b | CN¥192.85 | PE25.6x | E33.3% | 0.3% | Tech | ||
NU | US$13.70 | -0.2% | 32.2% | US$65.9b | US$15.06 | PB8.6x | E24.9% | n/a | Banks | ||
A196170 | ₩394,000.00 | 0.6% | 334.4% | ₩21.0t | ₩565,000.00 | PS282.3x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
2345 | NT$725.00 | -6.3% | 29.9% | NT$405.2b | NT$789.38 | PE41.7x | E25.1% | 1.4% | Tech | ||
A012450 | ₩533,000.00 | 27.5% | 239.6% | ₩24.2t | ₩593,366.26 | PE35.8x | E30.0% | 0.4% | Capital Goods | ||
ALAB | US$87.85 | -13.3% | n/a | US$14.2b | US$124.53 | PS35.9x | E61.3% | n/a | Semiconductors | ||
300502 | CN¥109.01 | -3.9% | 98.6% | CN¥77.3b | CN¥161.36 | PE40.6x | E36.6% | 0.1% | Tech | ||
600989 | CN¥16.61 | 0.8% | 17.7% | CN¥121.8b | CN¥21.74 | PE19.3x | E38.5% | 1.7% | Materials | ||
ITCI | US$127.82 | 0.6% | 69.0% | US$13.6b | US$132.73 | PS22.1x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
SMCI | US$47.91 | 32.1% | -40.4% | US$28.1b | US$47.52 | PE23.2x | E27.6% | n/a | Tech | ||
PME | AU$283.53 | -0.08% | 225.0% | AU$29.6b | AU$254.50 | PE301.4x | E23.6% | 0.2% | Healthcare | ||
KSPI | US$109.19 | 12.5% | 14.3% | US$20.7b | US$131.43 | PE10.6x | E20.8% | 6.3% | Diversified Financials | ||
6669 | NT$2,045.00 | -6.6% | -10.5% | NT$380.0b | NT$3,015.59 | PE19.7x | E24.1% | 2.1% | Tech | ||
BAJFINANCE | ₹8,392.30 | -1.0% | 26.8% | ₹5.2t | ₹8,607.85 | PE32.5x | E23.2% | 0.4% | Diversified Financials | ||
SYM | US$27.06 | 2.6% | -37.1% | US$15.9b | US$34.32 | PS1.5x | E83.5% | n/a | Capital Goods | ||
PLTR | US$119.16 | 7.5% | 387.6% | US$271.4b | US$84.70 | PE587.3x | E29.0% | n/a | Software |